BAMBX | DMSZX | BAMBX / DMSZX | |
Total Expense Ratio | 1.20 | 1.22 | 98% |
Annual Report Gross Expense Ratio | 1.22 | 1.65 | 74% |
Fund Existence | 10 years | 7 years | - |
Gain YTD | 2.577 | 0.666 | 387% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.76B | 529M | 1,466% |
Annual Yield % from dividends | 3.74 | 6.40 | 59% |
Returns for 1 year | 5.70 | 4.29 | 133% |
Returns for 3 years | 16.63 | 23.03 | 72% |
Returns for 5 years | 17.04 | 33.11 | 51% |
Returns for 10 years | 33.04 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LHCVX | 18.50 | -0.10 | -0.54% |
Lord Abbett Health Care R6 | |||
BUISX | 14.08 | -0.23 | -1.61% |
Buffalo Small Cap Growth Institutional | |||
OIGCX | 31.08 | -0.52 | -1.65% |
Invesco Oppenheimer International Gr C | |||
ARRBX | 13.70 | -0.23 | -1.65% |
Aristotle Small Cap Equity R6 | |||
VEIGX | 37.59 | -0.65 | -1.70% |
Vanguard Global ESG Select Stk Investor |